1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 19 to 90 Sponsor: Other Protocol IDs: SuMo-Sec-01, PEI 0899/01, IRB 07/03, NCT00108875
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: 2006-003619-29, NCT01272466
|
|
3.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: P009-2010DR1082, NCT01308294
|
|
4.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-09-C-0051, 09-C-0051, NCI-P08428, NCT00814684
|
|
5.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 to 85 Sponsor: NHLBI Protocol IDs: 060062, 06-H-0062, NHLBI-06-H-0062, NCT00270452
|
|
6.
|
Phase: Phase I Type: Treatment Status: Active Age: 20 to 80 Sponsor: Other Protocol IDs: AUGIS-001, NCT00624182
|
|
7.
|
Phase: Phase I Type: Treatment Status: Active Age: 20 to 80 Sponsor: Other Protocol IDs: TPR07-079, NCT00632333
|
|
8.
|
Phase: Phase I Type: Treatment Status: Active Age: 20 to 85 Sponsor: Other Protocol IDs: SUMS-21-72, UMIN000003189, NCT01069575
|
|
9.
|
Phase: Phase I Type: Treatment Status: Active Age: 20 to 75 Sponsor: Other Protocol IDs: SUMS-21-74, UMIN000003191, NCT01069653
|
|
10.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: LU 1006 - IDO, NCT01219348
|
|
11.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: I 171010, NCI-2010-02042, NCT01250470
|
|
12.
|
Phase: Phase I Type: Treatment Status: Active Age: 20 to 85 Sponsor: Other Protocol IDs: MBCCTA-001-STT, NCT01259505
|
|
13.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 110396, NCT01390064
|
|
14.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 15781, NCT01585350
|
|
15.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Treatment Status: Active Age: 18 to 85 Sponsor: NCI Protocol IDs: UVACC-MEL-38, UVACC-14499, UVACC-HIC-8380
|
|
16.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MCC-15025, INNO-305 WT-1, 105946, NCT00665002
|